Alberto Elli is a global business leader with more than three decades of experience in finance, sales, marketing, and supply chain. He has worked in various industries and organizations, from large listed companies to startups, with proven success in directing turnarounds and crisis management. Among his notable accomplishments, Mr. Elli raised $10M from VCs for a startup, Aquaro Histology Inc., and managed M&A and divestures, directing teams acquiring more than 20 companies ($5M to $350M) creating a process to integrate acquired entities. He holds a degree in Dottore in Economia e Commercio with specialization in Accounting and Control from Università Bocconi.

Over the years, Mr. Elli gained expertise in chemicals, pharmaceuticals, biotechnology, medical devices, capital equipment, consumer goods (healthcare, fashion, electronics), and entertainment. He worked as Sr. Director, Finance and M&A at Tada Cognitive Solutions, President and Chief Operating Officer at QubicaAMF Worldwide, Chief Executive Officer at Aquaro Histology, Interim - CFO at D+M Group, Founder and CEO at Pever M&A and Startup Consulting, Chief Financial Officer at Geneva Watch Group, Group VP and Controller Global Finishes Group at Sherwin-Williams, Controller NH-NAR at CNH Industrial, Interim - Chief Financial Officer at Valmed SA, VP Finance International at Merck, VP Finance HealthCare Division at Merck, Finance Director (CFO) Italy at Merck, and Finance Director (CFO) Italy at SCA - Hygiene and Forest Products Company.